Recordati SpA (MIL:REC) Total Payout Yield %: 3.80 (As of Jul. 04, 2026)


MIL:REC Recordati SpA MIL:REC
94 GF Score
Price €51.35
GF Value €60.74
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Recordati SpA Total Payout Yield %?

Recordati SpA MIL:REC -0.48% 94 Total Payout Yield % is 3.80 as of Jul. 04, 2026. GuruFocus rates MIL:REC with a GF Score™ of 94/100 and a GF Value™ of €60.74 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Recordati SpA's current Total Payout Yield % is 3.80%.


Recordati SpA Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Recordati SpA Total Payout Yield % Related Terms


Recordati SpA Total Payout Yield % Historical Data

* Premium members only.

The historical data trend for Recordati SpA's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA Total Payout Yield % Chart

Recordati SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Payout Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.37 3.38 2.37 2.68 3.83

Recordati SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Payout Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 5.85 2.04 5.65 1.76

MIL:REC vs LLY, JNJ, ABBV: Total Payout Yield % Comparison

For the Drug Manufacturers - General subindustry, Recordati SpA's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA Total Payout Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Total Payout Yield % falls into.


MIL:REC
94GF Score
Recordati SpA MIL:REC
Total Payout Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Recordati SpA Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Recordati SpA's Total Payout Yield % for the fiscal year that ended in Dec. 2025 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (-157.055 + 44.561 + -267.556) / 9919.44024
=3.83%

Recordati SpA's annualized Total Payout Yield % for the quarter that ended in Mar. 2026 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (-43.952 + 0.328 + -0.214) * 4 / 9976.10912
=1.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Yield % →
What does a Total Payout Yield % of 3.80 mean?
Recordati SpA (MIL:REC) has a Total Payout Yield % of 3.80 as of Jul. 04, 2026. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Recordati SpA and its competitors.
Is Recordati SpA's Total Payout Yield % too high?
Recordati SpA's current Total Payout Yield % is 3.80. Overall, Recordati SpA has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Recordati SpA's Total Payout Yield % compare to LLY and JNJ?
Recordati SpA's Total Payout Yield % of 3.80 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Yield % for a Drug Manufacturers company?
A good Total Payout Yield % depends on the Drug Manufacturers industry context. However, Total Payout Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Yield % mean?
A high Total Payout Yield % can signal that a stock is expensive relative to its fundamentals. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Recordati SpA and its competitors. Recordati SpA's current Total Payout Yield % is 3.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Recordati SpA stock overvalued right now?
Based on GuruFocus' analysis, Recordati SpA (MIL:REC) is currently considered Modestly Undervalued. The stock's GF Value™ is €60.74, compared to a current price of €51.35 — trading 15.5% below its estimated fair value. The current Total Payout Yield % is 3.80. Recordati SpA's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Yield % calculated?
Total Payout Yield % is calculated from a company's financial statements. For Recordati SpA (MIL:REC), the current Total Payout Yield % is 3.80 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Recordati SpA (MIL:REC) Overvalued in 2026?

Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued. The current stock price of €51.35 is trading 15.5% below its estimated GF Value™ of €60.74. GuruFocus considers Recordati SpA to be Modestly Undervalued.

Key valuation signals for MIL:REC:

  • Total Payout Yield %: 3.80
  • GF Value™: €60.74 vs. price of €51.35 (15.5% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the MIL:REC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Recordati SpA Business Description

Address Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
94GF Score

Get the complete analysis for MIL:REC

Total Payout Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.35
Price
€60.74
GF Value